In conclusion, the above results demonstrate that TSG-6 in BMSCs-Exo can inhibit the pyroptosis of IECs by regulating the NLRP3/Caspase-1 signaling axis, thus clarifying a new mechanism for BMSCs-Exo in the treatment of IBD. This evidence concerns the gene NLRP3 and inflammatory bowel disease.